Leukemia stem cells in acute myeloid leukemia

Area of Science:

• Oncology
• Stem Cell Biology
• Hematology

Background:

• Malignancies often exhibit a developmental hierarchy with cancer stem cells at the apex.
• Cancer stem cells are responsible for tumor growth, propagation, and relapse.
• Leukemia stem cells (LSCs) in acute myeloid leukemia (AML) are relatively resistant to conventional therapies.

Purpose of the Study:

• To review the molecular and cellular biology of LSCs and their niche in AML.
• To identify critical molecular pathways governing LSC function.
• To explore current and prospective therapeutic targets for LSC eradication.

Main Methods:

• Literature review focusing on LSC biology and AML.
• Analysis of molecular pathways essential for LSC maintenance and function.
• Identification of potential therapeutic strategies targeting LSCs.

Main Results:

• LSCs are crucial for AML initiation and maintenance.
• Specific molecular pathways are critical for LSC survival and self-renewal.
• Current therapies primarily target bulk leukemia cells, sparing LSCs, leading to relapse.

Conclusions:

• Targeting LSCs is essential for achieving durable remission in AML.
• Understanding LSC biology provides a basis for developing novel, more effective therapies.
• Therapeutic strategies aimed at eradicating LSCs hold promise for improving outcomes in AML and other cancers.